当前位置:
X-MOL 学术
›
J. Intern. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).
Journal of Internal Medicine ( IF 11.1 ) Pub Date : 2020-03-27 , DOI: 10.1111/joim.13063 J Wu 1, 2 , W Li 3 , X Shi 1 , Z Chen 2 , B Jiang 4 , J Liu 5 , D Wang 6 , C Liu 7 , Y Meng 8 , L Cui 2 , J Yu 1 , H Cao 1, 9 , L Li 1
Journal of Internal Medicine ( IF 11.1 ) Pub Date : 2020-03-27 , DOI: 10.1111/joim.13063 J Wu 1, 2 , W Li 3 , X Shi 1 , Z Chen 2 , B Jiang 4 , J Liu 5 , D Wang 6 , C Liu 7 , Y Meng 8 , L Cui 2 , J Yu 1 , H Cao 1, 9 , L Li 1
Affiliation
At present, the severity of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been a focal point.
中文翻译:
早期抗病毒治疗有助于减轻新型冠状病毒病(COVID-19)患者的病情并改善其预后。
目前,感染严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)的患者的严重程度已成为重点。
更新日期:2020-03-27
中文翻译:
早期抗病毒治疗有助于减轻新型冠状病毒病(COVID-19)患者的病情并改善其预后。
目前,感染严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)的患者的严重程度已成为重点。